Medication-Assisted Treatment

This webpage identifies the major literature in the field of substance abuse and child welfare practice: medication-assisted treatment. The time frame is from January 2000 through December 2014.

Fullerton, C. A., Kim, M., Thomas, C. P., Lyman, D. R., Montejano, L. B., Dougherty, R. H., Daniels, A. S., Ghose, S. S., & Delphin-Rittmon, M. E. (2014). Medication-Assisted Treatment with Methadone: Assessing the Evidence. Psychiatric Services, 65(2), pp. 146-157.

This article is a review of the literature on the evidence for methadone maintenance treatment’s (MMT) effectiveness. The authors rated the level of evidence (high, moderate, and low) based on benchmarks for the number of studies and quality of their methodology. They also described the evidence of service effectiveness and examined maternal and fetal results of MMT for pregnant women. MMT in pregnancy was associated with improved maternal and fetal outcomes, and rates of neonatal abstinence syndrome were similar for mothers receiving different doses. MMT is associated with improved outcomes for individuals and pregnant women with opioid use disorders.

Jerry, J. M., & Collins, G. B. (2013). Medication-assisted treatment of opiate dependence is gaining favor. Cleveland Clinic Journal of Medicine, 80(6), pp. 345-349.

People addicted to opiates are more likely to avoid returning to these drugs if they participate in a program that includes taking maintenance doses of methadone or buprenorphine than with an abstinence program. Although medical opinion has long been divided on the issue of abstinence vs medication-assisted treatment, the latter seems to be gaining respect as an evidence-based approach.

Back to Top
Back to Top